Allen & Overy hires AstraZeneca China GC in Asia IP push

1 Legal

1 Legal is a Division of 1 Media

1 Legal - 1 Lawyers - 1 Attorneys

 
Need Legal Clients  - Need a Lawyer
 
 

Former AstraZeneca general counsel for China David Shen has joined Allen & Overy (A&O) in Shanghai as part of the firm’s global IP push.

Shen will join the firm as the leader of the China IP and life sciences practice as a partner following regulatory approval.

He joined AstraZeneca in 2011 and was most recently the multinational pharmaceutical company’s general counsel for China. He started his career working at Bayer Corporation as a research chemist before joining Philadelphia-based law firm Knoble & Yoshida in the patent practice.

Shen is qualified in Pennsylvania, New Jersey and is registered to practice before the US Patent and Trademark office.

A&O global IP head Geert Glas said Shen’s appointment is part of the firm’s long-term global strategy to grow its IP platform.

“As China’s role in the global economy has grown in importance, increasingly many global patent conflicts of a significant and strategic nature have an important China component,” said Victor Ho, the firm’s Asia Pacific head of life sciences.

Last year, the firm hired four IP partners: Mark Heaney, David Stone, Marc Döring and Marjan Noor from Simmons & Simmons in London.

Allen & Overy outlines plans for major US IP push

The post Allen & Overy hires AstraZeneca China GC in Asia IP push appeared first on The Lawyer | Legal News and Jobs | Advancing the business of law.



1 Lawyers
1 Lawyers

1 Legal

#1 Lawyers Search Engine

1 Legal is part of the 1 Search Project

Practice Areas - News - Federal - State - Contact Us


1 Legal

1 Legal is a Division of 1 Media

1 Legal - 1 Lawyers - 1 Attorneys

 
Need Legal Clients  - Need a Lawyer